Subscribe
shutterstock_1732246315_repelsteeltje
Repelsteeltje / Shutterstock.com
5 February 2021BiotechnologyAlex Baldwin

Pfizer to collaborate with Imcyse on new immunotherapy programme

Pfizer has struck a research and licensing agreement with Belgium biopharmaceutical company Imcyse to develop treatments for rheumatoid arthritis (RA) using Imotopes - Imcyse’s platform of immunotherapeutics based on synthetic peptides.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.
Americas
Pfizer and Allergan merger talks at early stage
29 October 2015   Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.
Americas
Pfizer and Allergan merger talks at early stage
29 October 2015   Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger.

More on this story

Americas
BMS, Pfizer secure victory over generic makers
7 August 2020   In a victory for Bristol-Myers Squibb and Pfizer, a US federal judge has affirmed patents covering blood-thinner Eliquis.
Americas
Pfizer and Allergan merger talks at early stage
29 October 2015   Pharmaceutical company Pfizer has confirmed it has entered into talks with generics company Allergan over a potential merger.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool